Author: Daniel J Butler; Christopher Mozsary; Cem Meydan; David C Danko; Jonathan Foox; Joel Rosiene; Alon Shaiber; Ebrahim Afshinnekoo; Matthew MacKay; Fritz J Sedlazeck; Nikolay A Ivanov; Maria A Sierra; Diana Pohle; Michael Zeitz; Vijendra Ramlall; Undina Gisladottir; Craig D Westover; Krista Ryon; Benjamin Young; Chandrima Bhattacharya; Phyllis Ruggiero; Bradley W Langhorst; Nathan A Tanner; Justyn Gawrys; Dmitry Meleshko; Dong Xu; Jenny Xiang; Angelika Iftner; Daniela Bezdan; John Sipley; Lin Cong; Arryn Craney; Priya Velu; Ari Melnick; Iman A Hajirasouliha; Thomas Iftner; Mirella Salvatore; Massimo Loda; Lars F Westblade; Shawn Levy; Melissa Cushing; Nicholas P Tatonetti; Marcin Imielinski; Hanna Rennert; Christopher Mason
Title: Host, Viral, and Environmental Transcriptome Profiles of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Document date: 2020_4_20
ID: kyoa5gsf_6
Snippet: To optimize the LAMP assay for clinical samples, we first tested the reaction on a range of sample types, dilutions, and reaction volumes. We used a set of 201 COVID-19 samples that were tested for SARS-CoV-2 by qRT-PCR, including 69 nasopharyngeal (NP) swab samples that tested positive (clinical positives, qRT-PCR Ct<40) and 132 samples that tested negative (clinical negatives, qRT-PCR Ct ≥ 40) (see Methods). Clinically positive samples showed.....
Document: To optimize the LAMP assay for clinical samples, we first tested the reaction on a range of sample types, dilutions, and reaction volumes. We used a set of 201 COVID-19 samples that were tested for SARS-CoV-2 by qRT-PCR, including 69 nasopharyngeal (NP) swab samples that tested positive (clinical positives, qRT-PCR Ct<40) and 132 samples that tested negative (clinical negatives, qRT-PCR Ct ≥ 40) (see Methods). Clinically positive samples showed a much higher fluorescence than negative samples, with superior performance observed with higher (10µL vs 5µL) input volumes (Supp. Figure 3b) . Clinically positive samples that failed to generate LAMP fluorescence were associated with lower viral genome abundance (high cycle threshold [Ct] value qRT-PCR). We obtained similar performance on bulk oropharyngeal swab lysate (Supp. Figure 3c -e), including increasing reaction sensitivity as a function of viral copy number. This required only a 30-minute lysis time for the oral collections and 30-minute LAMP reaction time. These results indicate robust performance of the LAMP assay across a broad range of purified nucleic acids as well as crude cellular lysates (see Methods).
Search related documents:
Co phrase search for related documents- high cycle threshold and nucleic acid: 1, 2
- high cycle threshold and PCR Ct: 1, 2, 3, 4, 5, 6, 7, 8
- high cycle threshold and positive sample: 1, 2
- high cycle threshold and reaction time: 1, 2, 3, 4, 5
- high cycle threshold and sample type: 1, 2
- high fluorescence and nucleic acid: 1, 2, 3, 4, 5, 6, 7
- high fluorescence and swab sample: 1
- nucleic acid and oral collection: 1, 2
- nucleic acid and PCR Ct: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55
- nucleic acid and positive clinical positive: 1, 2
- nucleic acid and positive sample: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52
- nucleic acid and reaction sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
- nucleic acid and reaction time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- nucleic acid and reaction volume: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- nucleic acid and sample type: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- nucleic acid and similar performance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- nucleic acid and superior performance: 1, 2, 3, 4, 5, 6, 7
- nucleic acid and swab sample: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36
- nucleic acid and viral copy number: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date